JP2007509960A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509960A5
JP2007509960A5 JP2006538253A JP2006538253A JP2007509960A5 JP 2007509960 A5 JP2007509960 A5 JP 2007509960A5 JP 2006538253 A JP2006538253 A JP 2006538253A JP 2006538253 A JP2006538253 A JP 2006538253A JP 2007509960 A5 JP2007509960 A5 JP 2007509960A5
Authority
JP
Japan
Prior art keywords
disorders
pharmaceutical composition
composition according
nzojiazepin
depressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006538253A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/035822 external-priority patent/WO2005044818A2/en
Publication of JP2007509960A publication Critical patent/JP2007509960A/ja
Publication of JP2007509960A5 publication Critical patent/JP2007509960A5/ja
Withdrawn legal-status Critical Current

Links

JP2006538253A 2003-10-28 2004-10-28 イミダゾ［１，２−ａ］ピリジン抗不安薬 Withdrawn JP2007509960A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51504303P 2003-10-28 2003-10-28
PCT/US2004/035822 WO2005044818A2 (en) 2003-10-28 2004-10-28 Imidazo[1,2-a]pyridine anxiolytics

Publications (2)

Publication Number Publication Date
JP2007509960A JP2007509960A (ja) 2007-04-19
JP2007509960A5 true JP2007509960A5 (enExample) 2007-11-29

Family

ID=34572796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538253A Withdrawn JP2007509960A (ja) 2003-10-28 2004-10-28 イミダゾ［１，２−ａ］ピリジン抗不安薬

Country Status (8)

Country Link
US (3) US7723324B2 (enExample)
EP (1) EP1682549B1 (enExample)
JP (1) JP2007509960A (enExample)
AT (1) ATE482211T1 (enExample)
AU (1) AU2004287847A1 (enExample)
CA (1) CA2544213A1 (enExample)
DE (1) DE602004029272D1 (enExample)
WO (1) WO2005044818A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1966201A1 (en) * 2005-11-28 2008-09-10 Mallinckrodt, Inc. Improved method of preparation for imidazolepyridines
EP1803722A1 (en) * 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
AU2009249186B2 (en) 2008-05-19 2014-05-22 Sunovion Pharmaceuticals Inc. Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators
WO2011041713A2 (en) * 2009-10-02 2011-04-07 Glaxosmithkline Llc Piperazinyl antiviral agents
PH12012500778A1 (en) 2009-10-30 2012-11-26 Janssen Pharmaceutica Nv IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
TR201906779T4 (tr) * 2011-05-12 2019-05-21 Proteostasis Therapeutics Inc Proteostaz regülatörleri.
JP6115962B2 (ja) 2011-06-27 2017-04-19 ヤンセン ファーマシューティカ エヌ．ベー． １−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体
WO2014001314A1 (en) 2012-06-26 2014-01-03 Janssen Pharmaceutica Nv Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
AU2013289284B2 (en) 2012-07-09 2017-03-30 Janssen Pharmaceutica Nv Inhibitors of phosphodiesterase 10 enzyme
ES2689429T3 (es) * 2012-07-13 2018-11-14 Ucb Biopharma Sprl Derivados de imidazopiridina como moduladores de actividad de TNF
TWI648281B (zh) * 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
TW201601632A (zh) 2013-11-20 2016-01-16 杜邦股份有限公司 １－芳基－３－烷基吡唑殺蟲劑
UA125012C2 (uk) 2014-07-02 2021-12-29 ЕфЕмСі КОРПОРЕЙШН Піперидинонові гербіциди
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
CN107383005B (zh) * 2017-09-11 2020-03-13 华东理工大学 6-甲基-2-(4-甲基苯基)咪唑并[1,2-a]吡啶-3-乙酸的制备方法
CN113387946B (zh) * 2021-05-17 2023-08-01 衡阳师范学院 一种超声辅助多组分合成2-苯基-3-芳胺甲基咪唑并吡啶衍生物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU522187A1 (ru) * 1975-03-12 1976-07-25 Военная Краснознаменная академия химической защиты им.Маршала Советского Союза С.К.Тимошенко Способ получени 3-ацил-2-алкил (арил)-имидазо (1,2 )пиридинов
FR2492382A1 (fr) 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
EP0226641B1 (en) 1985-05-25 1989-10-18 Yoshitomi Pharmaceutical Industries, Ltd. Oxodiazine compounds
FR2647451B1 (fr) * 1989-05-26 1994-08-05 Sanofi Sa Derives d'imidazo(1,2-a)pyridine, procede de preparation, compositions pharmaceutiques les contenant
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6514969B2 (en) * 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
SE0100568D0 (sv) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
SE0100567D0 (sv) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
CA2450555A1 (en) 2001-06-25 2003-01-03 Merck & Co., Inc. (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
CA2484631A1 (en) 2002-05-13 2003-11-27 Merck & Co., Inc. Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles

Similar Documents

Publication Publication Date Title
CY2025003I2 (el) Λιποσωματα για τη χορηγηση φαρμακων συνθεσεις για τη θεραπευτικη αγωγη γαστρεντερικων διαταραχων
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
MX2011011489A (es) Derivados de isoxazol-piridina.
MX2009014001A (es) Derivados de isoxazol-imidazol.
MX2011011477A (es) Derivados de isoxazol-piridazina.
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
MX2011007774A (es) Derivados de isoxazol-isoxazol e isoxazol-isotiazol.
MX2011011273A (es) Derivados de isoxazol-pirazol.
MY147442A (en) Imidazoquinolines as lipid kinase inhibitors
UA100132C2 (en) Isoxazolo-pyridine derivatives
PA8534801A1 (es) Derivados de piperazina
MX2009000385A (es) Acil-anilidas sustituidas y metodos de uso de las mismas.
MX354423B (es) Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
PA8564001A1 (es) Aza-arilpiperazinas
JP2003531157A5 (enExample)
MX2010005753A (es) Derivados de isoxazolo-pirazina.
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
EA201071006A1 (ru) Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности
JP2007516193A5 (enExample)
WO2007084622A3 (en) Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2011011490A (es) Derivados de isoxazol-tiazol como agonistas inversos del receptor de acido gamma-aminobutirico a (gaba a), para usarse en el tratamiento de trastornos cognitivos.
JP2005508872A5 (enExample)
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
MX2009005544A (es) Indoles.